PFIZER INC Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Tax (Deprecated 2012-01-31)
PFIZER INC (PFE) reported Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Tax (Deprecated 2012-01-31) of $7.00 million for the 3-month period ending 2012-04-01, per its 10-Q filed 2012-05-10.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeTax · last filed 2012-05-10
- PFIZER INC other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, tax (deprecated 2012-01-31) for the quarter ending 2012-04-01 was $7.00M, a 600.00% increase year-over-year.
- PFIZER INC other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, tax (deprecated 2012-01-31) for the quarter ending 2011-04-03 was $1.00M.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Tax (Deprecated 2012-01-31) 3 month |
|---|---|
| 2012-04-01 | $7.00M 10-Q · filed 2012-05-10 |
| 2011-04-03 | $1.00M 10-Q · filed 2012-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |